Developer docs
API playgroundTry for free, no card

Search company profiles

Sree Chitra Tirunal Institute for Medical Sciences and Technology

Full company profile

uuid0038uz5

Namestring
Sree Chitra Tirunal Institute for Medical Sciences and Technology
Legal namestring
Sree Chitra Tirunal Institute for Medical Sciences and Technology
Websiteurl
sctimst.ac.in
Company typeenum
Private
Founded yearint
1973
Descriptiontext

Sree Chitra Tirunal Institute for Medical Sciences and Technology (SCTIMST) is a government-owned Institution of National Importance established by an Act of Parliament in 1980 and operating under the Department of Science and Technology, Government of India. Headquartered in Thiruvananthapuram, Kerala, the institute is structured around three wings: a 253-bed tertiary referral super-specialty hospital focused on cardiovascular, thoracic, and neurological diseases; the BioMedical Technology Wing (BMT Wing) at Satelmond Palace, which handles medical device development, biomaterials, biocompatibility, tissue engineering, and product incubation; and the Achutha Menon Centre for Health Science Studies (AMCHSS), a centre of excellence for public health training and research.

The institute's technology platform spans indigenous development of cardiac devices (heart valves, blood pumps, LVADs, vascular grafts), neuro-prosthetic devices (deep brain stimulators, intracranial electrodes), hard tissue implants (bioceramics, bioactive composites, bone cements), in vitro diagnostics (multiplex RT-PCR kits, RNA isolation kits), and biomaterials/tissue engineering products. Supporting infrastructure includes the Technical Research Centre (TRC) for Biomedical Devices approved by DST, a CDSCO-registered medical device testing laboratory accredited by COFRAC (France) and NABL, the TIMed technology business incubator, and a Centre of Excellence for Minimally Invasive Cardiovascular Devices sanctioned by DBT. The institute holds more than 100 patents and operates technology transfer arrangements with at least ten commercial manufacturers.

The business model rests on three revenue pillars: government grants (DST, DBT, state, and project-specific funding) as the primary capital base; subsidized tertiary healthcare services delivered through the Hospital Wing; and a commercial layer comprising technology transfer royalties, medical device testing and calibration services, academic fees (MPH, DPH, PhD, post-doctoral, and diploma programs), and incubator-driven startup activity. The institution has no equity shareholders, no PE/VC involvement, and operates as a government-controlled entity with academic and translational research outputs rather than profit motive.

Short descriptiontext

SCTIMST is a government-owned Institution of National Importance under India's DST, operating a 253-bed tertiary hospital for cardiac and neurological care, a BioMedical Technology Wing for indigenous medical device development and testing, and a public health centre, with technology transfer to industry.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1,001–5,000
akta.pro rankint
HeadquartersThiruvananthapuram, India
HQ citystring
Thiruvananthapuram
HQ countrystring
India
HQ regionstring
Asia
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
tertiary cardiac care, biomedical device development, tissue engineering, public health research, biomaterials research
NAICS code4 codes
  • General Medical and Surgical Hospitals622110
  • Surgical and Medical Instrument Manufacturing339112
  • Surgical Appliance and Supplies Manufacturing339113
  • Scientific Research and Development Services5417
SIC code3 codes
  • Services-General Medical & Surgical Hospitals, Nec8062
  • Surgical & Medical Instruments & Apparatus3841
  • Orthopedic, Prosthetic & Surgical Appliances & Supplies3842
Product category
Tertiary Healthcare & Biomedical Research
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Infrastructure, Operations, Supply Chain
GTM typeB2B and B2C
B2B and B2C
Offering typeServices
Services
Brand1 of 4 records shown
1TIMed
Description

Technology Business Incubator for Medical Devices & Biomaterials - a not-for-profit registered society promoted by SCTIMST for encouraging innovation and entrepreneurship in medical technologies

sctimst.ac.in
+3 more records
Core offering1 text field

SCTIMST operates a 253-bed super-specialty tertiary hospital providing cardiac, thoracic, and neurological patient care, alongside a Biomedical Technology Wing that designs, develops, prototypes, tests, and transfers indigenous medical devices, biomaterials, and tissue-engineered products to industry, and an academic centre offering postgraduate training and public-health research programs. The institute combines clinical service delivery with biomedical R&D and academic training under a single Institution of National Importance established under the Department of Science and Technology, Government of India.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

SCTIMST operates as an Institution of National Importance under the Department of Science and Technology, Govt. of India, comprising three main wings: Hospital Wing (tertiary referral super-specialty hospital with 253 beds for cardiovascular, thoracic, and neurological diseases), BioMedical Technology Wing (medical device development, biomaterials, and commercialization), and Achutha Menon Centre for Health Science Studies (public health excellence). Supporting infrastructure includes TIMed (technology business incubator), Technical Research Center (TRC) for biomedical devices, and Medical Device Testing Services (CDSCO-registered, COFRAC/NABL accredited). The institute provides specialized services including technology transfer, patient portals, emergency helplines (stroke, heart attack), and the Centre of Excellence for Minimally Invasive Cardiovascular Devices. Academic programs span post-doctoral courses, MPH, DPH, PhD, and various diploma programs in medical specialties.

Product and service6 records
1Tertiary Cardiac, Thoracic and Neurological Hospital Services
CategoryTertiary healthcare services
Description

Inpatient and outpatient super-specialty clinical services covering diagnosis, interventional cardiology, cardiac and thoracic surgery, neurology, neurosurgery, and allied specialties, delivered through a 253-bed referral hospital for patients referred from across Kerala and other Indian states.

2Biomedical Device Development and Technology Transfer
CategoryBiomedical technology R&D and licensing
Description

End-to-end development, prototyping, preclinical evaluation, and licensing/transfer of indigenous medical devices, biomaterials, and implants to industry partners, primarily Indian medical-device manufacturers.

3Tissue Engineering and Biomaterials Programs
CategoryBiomedical research
Description

Research and development programs in tissue engineering, regenerative medicine, and biomaterials, including the creation and characterization of scaffolds, hydrogels, and implants for clinical applications.

4Medical Device Testing and Evaluation Services
CategoryContract research and testing services
Description

In-vivo and in-vitro preclinical testing, biocompatibility evaluation, and regulatory-grade assessment of medical devices and biomaterials for industry and academic clients.

5Postgraduate and Doctoral Academic Programs
CategoryHigher education and research training
Description

Postgraduate, doctoral, and postdoctoral training programs in super-specialty medicine, biomedical technology, and public health, including DM, MCh, MPH, PhD, and diploma-level courses.

6Public Health Research and Training (AMCHSS)
CategoryPublic health education and research
Description

Public-health research, health-systems training, epidemiology, and health-policy studies delivered through the Achutha Menon Centre for Health Science Studies, including MPH and doctoral programs and policy studies for government and NGO partners.

Scale indicator8 records

Each record includes

Type, Value, Description, Source

Partnership20 partners
Strategic tierMajorTypeStrategic or Co-development Partner
Description

International research collaboration in public health. AMCHSS has collaborative research activities with University of Arizona in areas of non-communicable diseases and health equity research.

Strategic tierMajorTypeStrategic or Co-development Partner
Description

International research collaboration in public health studies. Collaboration focuses on tobacco cessation research and health policy studies.

Strategic tierMajorTypeStrategic or Co-development Partner
Description

International research collaboration in public health. Joint research activities in epidemiology and health systems research.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

International collaboration in public health research activities.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

International collaboration in public health research activities.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Technology transfer of artificial heart valve technology to TTTK Healthcare Limited. One of the first successful commercialization of indigenous medical device technology.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Technology transfer of blood bag, hydrocephalus shunt, and intrauterine device technologies. Major commercialization partner for multiple products.

8Siddharth Lifesciences Limited
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Technology transfer of membrane oxygenator and cardiotomy reservoir technologies.

sctimst.ac.in
9Basic Healthcare Limited
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Technology transfer of bio-ceramic composites for dental and orthopedic applications.

sctimst.ac.in
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Technology transfer of dental composite materials.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Technology transfer of Chitra RNA Isolation Kit and Vein Viewer (MISPA View) products.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Technology transfer of Multiplex RT PCR Kit for COVID-19 detection (targeting SARS-CoV-2 genes RdRp, ORF1b-nsp14 and human RNase P gene as internal control).

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Technology transfer of Chitra Emergency Breathing Assist Device.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Technology transfer of Fractl-TCP Granules (calcium sulfate cement), Caspero-Calcium Sulfate Cement, and Bonix Bone Cement products.

15Cyto Science Private Limited
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Technology transfer of Chitra Jelma Bio Ink for biomedical applications.

sctimst.ac.in
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Joint M.Tech (Clinical Engineering) and Ph.D (Biomedical Devices and Technology) programs with IIT Madras.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Joint academic programs including M.Sc Bioengineering, Ph.D in Bioengineering/Biomedical Sciences, and Master of Public Health. Affiliated programs through CMC Vellore.

18National Institute of Epidemiology, Chennai
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Affiliated programs for MPH in Epidemiology and Health Systems, and PG Diploma in HIV Epidemiology through NIE Chennai.

sctimst.ac.in
19Athena SWAN (UK)
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Partnership under GATI (Gender Advancement for Transforming Institutions) initiative for gender equity in STEM fields. Collaborating with Athena Swan UK for transforming institutional approaches to gender equality.

sctimst.ac.in
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Research partnership on tobacco cessation research in India and Indonesia, funded by Fogarty International Center, National Institutes of Health, USA.

Recent move9 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeEmerging player
Description

Partner institution running joint M.Tech (Clinical Engineering) and PhD (Biomedical Devices) programs with SCTIMST. Comparable as an adjacent biomedical engineering and medical device R&D center with overlapping translational capabilities.

TypeDirect peer
Description

Autonomous super-specialty teaching hospital under the Uttar Pradesh government providing tertiary care, postgraduate medical training, and clinical research. Comparable as an Indian state-supported tertiary specialty institution with similar academic and translational mandates.

TypeDirect peer
Description

Autonomous Indian government institute of national importance specializing in neurology, neurosurgery, and mental health with combined clinical, academic, and research mandates. Strongly overlaps with SCTIMST's neurology and neurosurgery focus.

TypeDirect peer
Description

Major not-for-profit tertiary hospital and medical school with deep R&D output and a long-running joint academic partnership with SCTIMST. Comparable as a high-volume specialty institution that also trains postgraduate students and conducts applied clinical research.

TypeDirect peer
Description

Autonomous Institution of National Importance under the Ministry of Health providing tertiary specialty care, postgraduate medical education, and biomedical research. Closely mirrors SCTIMST's structure of combined clinical, academic, and research missions funded by the Indian government.

TypeBroad incumbent
Description

Sweden's academic medical research center combining a research-intensive medical university with a tertiary specialty hospital. Comparable as a publicly funded institution combining clinical care, biomedical research, and translational output.

TypeDirect peer
Description

Indian tertiary care teaching hospital with biomedical research and postgraduate medical programs. Comparable as a multi-wing academic medical institution serving patient care, education, and applied medical research in a single campus model.

TypeDirect peer
Description

India's flagship Institution of National Importance and tertiary super-specialty hospital with parallel mandates in patient care, biomedical research, and postgraduate training. Directly comparable as a publicly funded academic medical center of similar scope and prestige.

TypeDirect peer
Description

Government of India Institution of National Importance offering tertiary specialty care, postgraduate training, and research. Comparable as a southern Indian peer with overlapping patient care, academic, and translational research roles.

TypeBroad incumbent
Description

U.S. government-funded biomedical research hospital combining intramural research, clinical trials, and academic training. Comparable as a sovereign-backed academic medical research institution, though at materially larger scale and broader scope.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Subsidiaries5 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Sree Chitra Tirunal Institute for Medical Sciences and Technology

Tertiary Healthcare & Biomedical Researchsctimst.ac.in

SCTIMST is a government-owned Institution of National Importance under India's DST, operating a 253-bed tertiary hospital for cardiac and neurological care, a BioMedical Technology Wing for indigenous medical device development and testing, and a public health centre, with technology transfer to industry.

What Sree Chitra Tirunal Institute for Medical Sciences and Technology does

Sree Chitra Tirunal Institute for Medical Sciences and Technology (SCTIMST) is a government-owned Institution of National Importance established by an Act of Parliament in 1980 and operating under the Department of Science and Technology, Government of India. Headquartered in Thiruvananthapuram, Kerala, the institute is structured around three wings: a 253-bed tertiary referral super-specialty hospital focused on cardiovascular, thoracic, and neurological diseases; the BioMedical Technology Wing (BMT Wing) at Satelmond Palace, which handles medical device development, biomaterials, biocompatibility, tissue engineering, and product incubation; and the Achutha Menon Centre for Health Science Studies (AMCHSS), a centre of excellence for public health training and research.

The institute's technology platform spans indigenous development of cardiac devices (heart valves, blood pumps, LVADs, vascular grafts), neuro-prosthetic devices (deep brain stimulators, intracranial electrodes), hard tissue implants (bioceramics, bioactive composites, bone cements), in vitro diagnostics (multiplex RT-PCR kits, RNA isolation kits), and biomaterials/tissue engineering products. Supporting infrastructure includes the Technical Research Centre (TRC) for Biomedical Devices approved by DST, a CDSCO-registered medical device testing laboratory accredited by COFRAC (France) and NABL, the TIMed technology business incubator, and a Centre of Excellence for Minimally Invasive Cardiovascular Devices sanctioned by DBT. The institute holds more than 100 patents and operates technology transfer arrangements with at least ten commercial manufacturers.

The business model rests on three revenue pillars: government grants (DST, DBT, state, and project-specific funding) as the primary capital base; subsidized tertiary healthcare services delivered through the Hospital Wing; and a commercial layer comprising technology transfer royalties, medical device testing and calibration services, academic fees (MPH, DPH, PhD, post-doctoral, and diploma programs), and incubator-driven startup activity. The institution has no equity shareholders, no PE/VC involvement, and operates as a government-controlled entity with academic and translational research outputs rather than profit motive.

Sree Chitra Tirunal Institute for Medical Sciences and Technology firmographics

Firmographics
Name
Sree Chitra Tirunal Institute for Medical Sciences and Technology
Legal name
Sree Chitra Tirunal Institute for Medical Sciences and Technology
Website
https://sctimst.ac.in
Company type
Private
Founded year
1973
Operating status
Operating
Headcount range
1,001–5,000 employees
Short description
SCTIMST is a government-owned Institution of National Importance under India's DST, operating a 253-bed tertiary hospital for cardiac and neurological care, a BioMedical Technology Wing for indigenous medical device development and testing, and a public health centre, with technology transfer to industry.
Ownership category
akta.pro rank

Where Sree Chitra Tirunal Institute for Medical Sciences and Technology is headquartered

Location

Headquarters

HQ city
Thiruvananthapuram
HQ country
India
HQ region
Asia

Offices3 records

Markets served

Sree Chitra Tirunal Institute for Medical Sciences and Technology business model

Business model
GTM type
B2B and B2C
Offering type
Services
Cost components
Personnel, Technology or R&D, Infrastructure, Operations, Supply Chain

Distribution channels5 records

Marketing channels8 records

Sree Chitra Tirunal Institute for Medical Sciences and Technology product offering

Product offering

Core offering

SCTIMST operates a 253-bed super-specialty tertiary hospital providing cardiac, thoracic, and neurological patient care, alongside a Biomedical Technology Wing that designs, develops, prototypes, tests, and transfers indigenous medical devices, biomaterials, and tissue-engineered products to industry, and an academic centre offering postgraduate training and public-health research programs. The institute combines clinical service delivery with biomedical R&D and academic training under a single Institution of National Importance established under the Department of Science and Technology, Government of India.

Product overview

SCTIMST operates as an Institution of National Importance under the Department of Science and Technology, Govt. of India, comprising three main wings: Hospital Wing (tertiary referral super-specialty hospital with 253 beds for cardiovascular, thoracic, and neurological diseases), BioMedical Technology Wing (medical device development, biomaterials, and commercialization), and Achutha Menon Centre for Health Science Studies (public health excellence). Supporting infrastructure includes TIMed (technology business incubator), Technical Research Center (TRC) for biomedical devices, and Medical Device Testing Services (CDSCO-registered, COFRAC/NABL accredited). The institute provides specialized services including technology transfer, patient portals, emergency helplines (stroke, heart attack), and the Centre of Excellence for Minimally Invasive Cardiovascular Devices. Academic programs span post-doctoral courses, MPH, DPH, PhD, and various diploma programs in medical specialties.

Differentiator

Problem solved

Functional benefit

Brands

  • TIMed: Technology Business Incubator for Medical Devices & Biomaterials - a not-for-profit registered society promoted by SCTIMST for encouraging innovation and entrepreneurship in medical technologies
  • TRC
  • AMCHSS
  • BMT Wing

Products and services

  • Tertiary Cardiac, Thoracic and Neurological Hospital Services Inpatient and outpatient super-specialty clinical services covering diagnosis, interventional cardiology, cardiac and thoracic surgery, neurology, neurosurgery, and allied specialties, delivered through a 253-bed referral hospital for patients referred from across Kerala and other Indian states.
  • Biomedical Device Development and Technology Transfer End-to-end development, prototyping, preclinical evaluation, and licensing/transfer of indigenous medical devices, biomaterials, and implants to industry partners, primarily Indian medical-device manufacturers.
  • Tissue Engineering and Biomaterials Programs Research and development programs in tissue engineering, regenerative medicine, and biomaterials, including the creation and characterization of scaffolds, hydrogels, and implants for clinical applications.
  • Medical Device Testing and Evaluation Services In-vivo and in-vitro preclinical testing, biocompatibility evaluation, and regulatory-grade assessment of medical devices and biomaterials for industry and academic clients.
  • Postgraduate and Doctoral Academic Programs Postgraduate, doctoral, and postdoctoral training programs in super-specialty medicine, biomedical technology, and public health, including DM, MCh, MPH, PhD, and diploma-level courses.
  • Public Health Research and Training (AMCHSS) Public-health research, health-systems training, epidemiology, and health-policy studies delivered through the Achutha Menon Centre for Health Science Studies, including MPH and doctoral programs and policy studies for government and NGO partners.

Companies that use Sree Chitra Tirunal Institute for Medical Sciences and Technology

Customer profile

Segments4 records

Ideal customer profiles3 records

Sree Chitra Tirunal Institute for Medical Sciences and Technology technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature6 records

Sree Chitra Tirunal Institute for Medical Sciences and Technology partnerships and signals

Strategic signal

Partnerships

20 partnerships are on record, tiered major, minor and core.

  • University of Arizona (USA)majorStrategic or Co-development PartnerInternational research collaboration in public health. AMCHSS has collaborative research activities with University of Arizona in areas of non-communicable diseases and health equity research.
  • University of Edinburgh (UK)majorStrategic or Co-development PartnerInternational research collaboration in public health studies. Collaboration focuses on tobacco cessation research and health policy studies.
  • Heidelberg University (Germany)majorStrategic or Co-development PartnerInternational research collaboration in public health. Joint research activities in epidemiology and health systems research.
  • Monash University (Australia)minorStrategic or Co-development PartnerInternational collaboration in public health research activities.
  • University of Melbourne (Australia)minorStrategic or Co-development PartnerInternational collaboration in public health research activities.
  • TTTK Healthcare LimitedcoreStrategic or Co-development PartnerTechnology transfer of artificial heart valve technology to TTTK Healthcare Limited. One of the first successful commercialization of indigenous medical device technology.
  • HLL Lifecare LimitedcoreStrategic or Co-development PartnerTechnology transfer of blood bag, hydrocephalus shunt, and intrauterine device technologies. Major commercialization partner for multiple products.
  • Siddharth Lifesciences LimitedcoreStrategic or Co-development PartnerTechnology transfer of membrane oxygenator and cardiotomy reservoir technologies.
  • Basic Healthcare LimitedcoreStrategic or Co-development PartnerTechnology transfer of bio-ceramic composites for dental and orthopedic applications.
  • Anabond Stedman Pharma LimitedcoreStrategic or Co-development PartnerTechnology transfer of dental composite materials.
  • Agappe Diagnostics LimitedcoreStrategic or Co-development PartnerTechnology transfer of Chitra RNA Isolation Kit and Vein Viewer (MISPA View) products.
  • Hueel Lifesciences Private LimitedcoreStrategic or Co-development PartnerTechnology transfer of Multiplex RT PCR Kit for COVID-19 detection (targeting SARS-CoV-2 genes RdRp, ORF1b-nsp14 and human RNase P gene as internal control).
  • Wipro Enterprises Private LimitedcoreStrategic or Co-development PartnerTechnology transfer of Chitra Emergency Breathing Assist Device.
  • Onyx Medicals Private LimitedcoreStrategic or Co-development PartnerTechnology transfer of Fractl-TCP Granules (calcium sulfate cement), Caspero-Calcium Sulfate Cement, and Bonix Bone Cement products.
  • Cyto Science Private LimitedminorStrategic or Co-development PartnerTechnology transfer of Chitra Jelma Bio Ink for biomedical applications.
  • IIT MadrascoreStrategic or Co-development PartnerJoint M.Tech (Clinical Engineering) and Ph.D (Biomedical Devices and Technology) programs with IIT Madras.
  • Christian Medical College VellorecoreStrategic or Co-development PartnerJoint academic programs including M.Sc Bioengineering, Ph.D in Bioengineering/Biomedical Sciences, and Master of Public Health. Affiliated programs through CMC Vellore.
  • National Institute of Epidemiology, ChennaiminorStrategic or Co-development PartnerAffiliated programs for MPH in Epidemiology and Health Systems, and PG Diploma in HIV Epidemiology through NIE Chennai.
  • Athena SWAN (UK)minorStrategic or Co-development PartnerPartnership under GATI (Gender Advancement for Transforming Institutions) initiative for gender equity in STEM fields. Collaborating with Athena Swan UK for transforming institutional approaches to gender equality.
  • Fogarty International Center, NIH (USA)minorStrategic or Co-development PartnerResearch partnership on tobacco cessation research in India and Indonesia, funded by Fogarty International Center, National Institutes of Health, USA.

Scale indicators8 records

Recent moves9 records

Expansion highlights6 records

Sree Chitra Tirunal Institute for Medical Sciences and Technology competitors and assessment

Company assessment

Emerging players

  • Indian Institute of Technology (IIT) Madras: Partner institution running joint M.Tech (Clinical Engineering) and PhD (Biomedical Devices) programs with SCTIMST. Comparable as an adjacent biomedical engineering and medical device R&D center with overlapping translational capabilities.

Direct peers

Broad incumbents

  • Karolinska Institutet / Karolinska University Hospital: Sweden's academic medical research center combining a research-intensive medical university with a tertiary specialty hospital. Comparable as a publicly funded institution combining clinical care, biomedical research, and translational output.
  • National Institutes of Health (NIH) Clinical Center: U.S. government-funded biomedical research hospital combining intramural research, clinical trials, and academic training. Comparable as a sovereign-backed academic medical research institution, though at materially larger scale and broader scope.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Sree Chitra Tirunal Institute for Medical Sciences and Technology social profiles

Digital presence

Sree Chitra Tirunal Institute for Medical Sciences and Technology compliance and trust

Trust signal

Compliance3 records

Sree Chitra Tirunal Institute for Medical Sciences and Technology financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Sree Chitra Tirunal Institute for Medical Sciences and Technology leadership team

Management profile

Number of profiles

Sree Chitra Tirunal Institute for Medical Sciences and Technology subsidiaries and ownership

Company hierarchy

Subsidiaries5 records

Sree Chitra Tirunal Institute for Medical Sciences and Technology funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Sree Chitra Tirunal Institute for Medical Sciences and Technology M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Sree Chitra Tirunal Institute for Medical Sciences and Technology

What does Sree Chitra Tirunal Institute for Medical Sciences and Technology do?

SCTIMST operates a 253-bed super-specialty tertiary hospital providing cardiac, thoracic, and neurological patient care, alongside a Biomedical Technology Wing that designs, develops, prototypes, tests, and transfers indigenous medical devices, biomaterials, and tissue-engineered products to industry, and an academic centre offering postgraduate training and public-health research programs. The institute combines clinical service delivery with biomedical R&D and academic training under a single Institution of National Importance established under the Department of Science and Technology, Government of India.

Is Sree Chitra Tirunal Institute for Medical Sciences and Technology a public or private company?

Sree Chitra Tirunal Institute for Medical Sciences and Technology is a private company. It is classified as state government owned and is currently operating.

When was Sree Chitra Tirunal Institute for Medical Sciences and Technology founded?

Sree Chitra Tirunal Institute for Medical Sciences and Technology was founded in 1973. It employs 1,001 to 5,000 people.

Where is Sree Chitra Tirunal Institute for Medical Sciences and Technology based?

Sree Chitra Tirunal Institute for Medical Sciences and Technology is headquartered in Thiruvananthapuram, India, in the Asia region.

Who are Sree Chitra Tirunal Institute for Medical Sciences and Technology's main competitors?

Indian Institute of Technology (IIT) Madras is listed as an emerging player. Direct peers are Sanjay Gandhi Postgraduate Institute of Medical Sciences (SGPGIMS), Lucknow, National Institute of Mental Health and Neurosciences (NIMHANS), Bangalore, Christian Medical College (CMC) Vellore, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, Sri Ramachandra Institute of Higher Education and Research, All India Institute of Medical Sciences (AIIMS), New Delhi and Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Puducherry. Broad incumbents are Karolinska Institutet / Karolinska University Hospital and National Institutes of Health (NIH) Clinical Center.

Does Sree Chitra Tirunal Institute for Medical Sciences and Technology have an API?

No public API is recorded for Sree Chitra Tirunal Institute for Medical Sciences and Technology.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Medical BuyerInnovation. SCTIMST launches its first coronary stentSree Chitra Tirunal Institute for Medical Sciences and Technology (SCTIMST) launched its first indigenously developed coronary stent, 'Chitra Core', through partner company Invasive Technologies Pvt Ltd. in India. The institute is also preparing the second stent, 'Chitra TiN', for pre-clinical evaluations ahead of a planned global launch.The Times of IndiaSree Chitra launches indigenous drug-eluting stentSree Chitra Tirunal Institute for Medical Sciences and Technology (SCTIMST) launched its indigenous drug-eluting stent, named Chitracore, in partnership with Invasive Technologies at a conference in Thiruvananthapuram. The device is manufactured locally to meet international quality standards while adhering to government pricing caps to ensure affordability for Indian patients. This development aims to reduce reliance on imported medical devices and support the 'Make in India' initiative in cardiovascular care.The HinduSCTIMST unveils Chitra Core, its first coronary stentSree Chitra Tirunal Institute for Medical Sciences and Technology (SCTIMST) has launched 'Chitra Core', a new coronary stent, at an event in Thiruvananthapuram on August 15, 2026. The stent is noted for its patented design and materials, featuring 30-40% less metal than conventional stents, which may reduce complications like restenosis and thrombosis. Additionally, a second stent, 'Chitra TiN', is in the pipeline for pre-clinical evaluations ahead of a global launch.BW Healthcare WorldWHO-SCTIMST Partnership For Indian MedTech Move From Labs To Global MarketsThe World Health Organization and the Sree Chitra Tirunal Institute for Medical Sciences and Technology (SCTIMST) signed a Memorandum of Understanding to facilitate technology transfer for medical devices, particularly targeting low- and middle-income countries. This partnership aims to bridge gaps in India's MedTech ecosystem by connecting laboratory innovations with scalable manufacturing and international markets, addressing the country's heavy reliance on imports.Medical BuyerSCTIMST, Tata Elxsi partner to boost MedTech developmentSree Chitra Tirunal Institute for Medical Sciences and Technology (SCTIMST) and Tata Elxsi signed a Memorandum of Understanding to collaborate on developing next-generation healthcare solutions and MedTech products for Indian and global markets. The partnership combines SCTIMST's expertise in cardiovascular sciences, neurosciences, and biotechnology with Tata Elxsi's capabilities in product engineering, design, AI, and digital technologies, creating an extended innovation ecosystem for medical device development. Initial efforts will focus on identifying high-potential opportunities across diagnostics, medical imaging, digital health, and biomedical engineering.The Times of India24-year-old HoFH-affected patient successfully treated | Thiruvananthapuram News - The Times of IndiaA 24-year-old patient with Homozygous Familial Hypercholesterolemia (HoFH) was successfully treated using LDL Apheresis at Sree Chitra Tirunal Institute for Medical Sciences and Technology in Thiruvananthapuram. The procedure, which removes excess LDL cholesterol from the bloodstream, was performed for the first time at the institute under cardiologists Harikrishnan S and Dr Manish Yadav. The patient had developed heart disease at a young age, previously underwent bypass surgery, and had dangerously high LDL levels of around 500 mg/dL that could not be controlled with conventional cholesterol-lowering medications.